Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.51 |
| ▸ | CYP4F2 | P78329 | 3/20 | 0.51 |
| ▸ | CYP4A11 | Q02928 | 3/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | POLB | P06746 | 2/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.45 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | SLC26A6 | Q9BXS9 | 1/20 | 0.44 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14783064 | 0.91 | ALDH1A1 (0.46) | ALDH1A1CYP4F2CYP4A11TSHRMAPT | |
| SCHEMBL6641439 | 0.89 | CYP4F2 (0.55) | ALDH1A1CYP4F2CYP4A11TSHRMAPT | |
| SCHEMBL9534495 | 0.88 | ALDH1A1 (0.46) | ALDH1A1TSHRMAPTPOLBHSD17B10 | |
| SCHEMBL28218075 | 0.87 | ALDH1A1 (0.49) | ALDH1A1MAPTPOLBHSD17B10USP2 | |
| SCHEMBL1645027 | 0.83 | ALDH1A1 (0.54) | ALDH1A1TSHRMAPTPOLBHSD17B10 | |
| SCHEMBL5883913 | 0.83 | ALDH1A1 (0.50) | ALDH1A1TSHRMAPTPOLBHSD17B10 | |
| SCHEMBL872744 | 0.83 | ALDH1A1 (0.47) | ALDH1A1TSHRMAPTPOLBHSD17B10 | |
| SCHEMBL28249604 | 0.82 | MAPT (0.46) | ALDH1A1TSHRMAPTHSD17B10USP2 | |
| SCHEMBL3952345 | 0.81 | ALDH1A1 (0.54) | ALDH1A1CYP4F2CYP4A11TSHRMAPT | |
| SCHEMBL28992323 | 0.81 | ALDH1A1 (0.49) | ALDH1A1MAPTPOLBHSD17B10USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 177 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117777070-A | Synthesis method of ethyl 2-furanpropionate | 济南悟通生物科技有限公司 | 2024-03-29 | — | — | CN | claimed |
| CN-103131185-B | A kind of cured liquid sealant composition and its preparation method and application on demand | 密封剂欧洲有限公司 | 2018-09-28 | — | — | CN | claimed |
| US-9850412-B2 | Cure-on-demand liquid sealant composition, process for the preparation thereof and uses thereof | SEALANTS EUROPE SAS (FR) | 2017-12-26 | — | — | US | claimed |
| EP-2599817-B1 | ON DEMAND CROSSLINKABLE LIQUID SEALING COMPOSITION, PROCESS THEREFOR AND ITS APPLICATION | HUTCHINSON (FR) | 2016-02-03 | — | — | EP | claimed |
| US-20150232725-A1 | Cure-On-Demand Liquid Sealant Composition, Process For The Preparation Thereof And Uses Thereof | PRC-DESOTO INTERNATIONAL, INC. | 2015-08-20 | — | — | US | claimed |
| CN-103131185-A | On demand crosslinkable liquid sealing composition, process therefor and its application | HUTCHINSON | 2013-06-05 | — | — | CN | claimed |
| US-20130137817-A1 | Cure-On-Demand Liquid Sealant Composition, Process For The Preparation Thereof And Uses Thereof | HUTCHINSON (FR) | 2013-05-30 | — | — | US | claimed |
| WO-2009131692-A1 | SUBSTRATES FOR DELIVERY OF PHYSIOLOGICALLY ACTIVE AGENTS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2009-10-29 | — | — | WO | claimed |
| JP-2003500486-A | — | — | 2003-01-07 | — | — | JP | claimed |
| EP-1185524-A2 | 3-HETEROARYLALKYL SUBSTITUTED GABA ANALOGS | WARNER-LAMBERT COMPANY (US) | 2002-03-13 | — | — | EP | claimed |
| WO-2000073296-A2 | 3-HETEROARYLALKYL SUBSTITUTED GABA ANALOGS | WARNER-LAMBERT COMPANY (US) | 2000-12-07 | — | — | WO | claimed |
| US-3978241-A | FURAN ESTER COMPOUNDS | FIRMENICH & CIE (CH) | 1976-08-31 | — | — | US | claimed |
| CN-117777070-B | Synthesis method of ethyl 2-furanpropionate | 济南悟通生物科技有限公司 | 2026-04-28 | — | — | CN | disclosed |
| CN-117777070-B | Synthesis method of ethyl 2-furanpropionate | 济南悟通生物科技有限公司 | 2026-04-28 | — | — | CN | disclosed |
| US-12552892-B2 | Grafting process of a Diels Alder adduct onto polypropylene | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2026-02-17 | — | — | US | disclosed |
| US-20260033524-A1 | FLAVOR MODIFYING COMPOSITIONS | CORN PRODUCTS DEV INC (US) | 2026-02-05 | — | — | US | disclosed |
| US-3952033-A | Furan intermediates and process for synthesis of 4-hydroxycyclopetenones, prostaglandin synthesis intermediates | AMERICAN CYANAMID COMPANY (US) | 1976-04-20 | — | — | US | disclosed |
| US-3943260-A | TETRAHYDRO-THIO-PHEN-3-ONES | FIRMENICH & CIE (CH) | 1976-03-09 | — | — | US | disclosed |
| US-3931246-A | FURYLALKYL-THIOETHERS | FIRMENICH & CIE (CH) | 1976-01-06 | — | — | US | disclosed |
| US-3931245-A | FURYLALKYLTHIOL CARBOXYLATES | FIRMENICH & CIE (CH) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12552892-B2 | Grafting process of a Diels Alder adduct onto polypropylene | ADH5, ADH1A, ADH1C | ALDH1A1 34/4885CYP4F2 75/4885CYP4A11 775/4885 |
| US-20260033524-A1 | FLAVOR MODIFYING COMPOSITIONS | TAS2R42, TAS2R7, TAS2R31 | ALDH1A1 970/4885CYP4F2 1520/4885CYP4A11 574/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.